First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

Clinical trial NCT06063070 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06063070
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer High Grade Serous Adenocarcinoma of Ovary High Grade Endometrioid Ovarian Cancer Primary Peritoneal Cancer Fallopian-tube Cancer

Start date: 2023-10-18
Primary completion: 2025-01-31
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.